| dc.contributor.author | Yesilbursa, Dogan | |
| dc.contributor.author | Uygur, Niyazi | |
| dc.contributor.author | Oncu, Fatih | |
| dc.contributor.author | Acuner, Tufan T. | |
| dc.contributor.author | Atlar, Fatmahan | |
| dc.contributor.author | Turkcan, Solmaz | |
| dc.date.accessioned | 2021-03-03T14:58:50Z | |
| dc.date.available | 2021-03-03T14:58:50Z | |
| dc.identifier.citation | Oncu F., Acuner T. T. , Atlar F., Turkcan S., Yesilbursa D., Uygur N., "Metabolic syndrome and related factors treated with antipsychotics monotherapy and polypharmacy in patients with schizophrenia", KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.19, 2009 | |
| dc.identifier.issn | 1017-7833 | |
| dc.identifier.other | av_3c8b2ef1-b586-4314-be8a-4632059cf9b8 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/44618 | |
| dc.description.abstract | Objective: The aim of our study was-to determine the prevalence of MetS and to investigate related factors-in the group of inpatients with schizophrenia treated with antipsychotics monotherapy (AM) and polypharmacy (AP). | |
| dc.language.iso | eng | |
| dc.subject | Temel Eczacılık Bilimleri | |
| dc.subject | Temel Bilimler | |
| dc.subject | FARMAKOLOJİ VE ECZACILIK | |
| dc.subject | Farmakoloji ve Toksikoloji | |
| dc.subject | Yaşam Bilimleri (LIFE) | |
| dc.subject | Psikiyatri | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Eczacılık | |
| dc.subject | Yaşam Bilimleri | |
| dc.title | Metabolic syndrome and related factors treated with antipsychotics monotherapy and polypharmacy in patients with schizophrenia | |
| dc.type | Makale | |
| dc.relation.journal | KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY | |
| dc.contributor.department | Istanbul Bakirkoy Mental Health & Neurology Training & Research Hospital , , | |
| dc.identifier.volume | 19 | |
| dc.contributor.firstauthorID | 191670 | |
